Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MILESTONE SCIENTIFIC INC. Director's Dealing 2014

Dec 30, 2014

34735_dirs_2014-12-30_8915a7d6-c2fe-4b14-820f-ab964c16cf4d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MILESTONE SCIENTIFIC INC. (MLSS)
CIK: 0000855683
Period of Report: 2014-12-17

Reporting Person: D'Agostino Joseph (CFO & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-17 Common stock M 50000 $1.15 Acquired 516339 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-17 Options to purchase common stock $1.15 M 50000 Disposed 2014-12-17 Common Stock, par value $.001 per share (50000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to purchase common stock $1.00 2015-12-20 Common Stock, par value $.001 per share (100000) 100000 Direct
Options to purchase common stock $1.00 2015-12-20 Common Stock, par value $.001 per share (100000) 100000 Direct
Options to purchase common stock $0.36 2016-12-31 Common Stock, par value $.001 per share (277778) 277778 Direct
Options to purchase common stock $1.28 2017-12-31 Common Stock, par value $.001 per share (78126) 78126 Direct
Options to purchase common stock $1.50 2018-12-31 Common Stock, par value $.001 per share (66666) 66666 Direct

Footnotes

F1: 377,108 shares of common stock to be issued at the termination of employment. On May 9, 2014 all 377,108 of these shares of common stock were issued to the reporting person.

F2: Immediately.

F3: These options are exercisable as follows: (i) for 1/3 on the date of grant (12-31-12); (ii) an additional 1/3 on the 1st anniversary of the date of grant; and (iii) an additional 1/3 on the second anniversary of the date of grant.

F4: These options are currently exercisable with the respect to 215,741 shares. The remaining 62,037 shares will vest on 12/31/2014.